---
title: "Gevo Earnings Report: Q4 Overview"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277985819.md"
description: "Gevo (NASDAQ:GEVO) released its Q4 earnings report on March 5, 2026, showing a 33.33% beat on estimated earnings with an EPS of $-0.02 compared to the estimate of $-0.03. Revenue increased to $39.65 million from the previous year. In the last quarter, Gevo also beat EPS estimates, but shares dropped 1.42% the following day. Historical performance shows fluctuations in EPS and revenue across previous quarters. For more details, visit Gevo's earnings calendar."
datetime: "2026-03-05T21:04:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277985819.md)
  - [en](https://longbridge.com/en/news/277985819.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277985819.md)
---

# Gevo Earnings Report: Q4 Overview

The Q4 earnings report for **Gevo** (NASDAQ:GEVO) was released on Thursday, March 5, 2026 at 04:01 PM.

Here's what investors need to know about the latest announcement.

### Earnings

Gevo beat estimated earnings by 33.33%, reporting an EPS of $-0.02 versus an estimate of $-0.03.

Revenue was up $39.65 million from the same period last year.

### Analysis of Past Earnings

The company beat on EPS by $0.02 in the last quarter, resulting in a 1.42% drop share price change the following day.

Here's a look at Gevo's past performance:

**Quarter**

**Q3 2025**

**Q2 2025**

**Q1 2025**

**Q4 2024**

**EPS Estimate**

\-0.05

\-0.05

\-0.10

\-0.09

**EPS Actual**

\-0.03

0.01

\-0.09

\-0.08

**Revenue Estimate**

36.33M

43.69M

26.35M

3.85M

**Revenue Actual**

42.71M

43.41M

29.11M

5.70M

To track all earnings releases for Gevo visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [GEVO.US](https://longbridge.com/en/quote/GEVO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [GEVX.US](https://longbridge.com/en/quote/GEVX.US.md)

## Related News & Research

- [Gevo withdraws from DoE loan program, will seek alternative funding for ATJ-30 project](https://longbridge.com/en/news/282905074.md)
- [Gevo Withdraws Financing Application With Department of Energy](https://longbridge.com/en/news/282904482.md)
- [Gossamer Bio Receives Nasdaq Minimum Bid Price Deficiency Notice](https://longbridge.com/en/news/282247265.md)
- [Pancreatic cancer pill shown to nearly double overall survival time, drug company says](https://longbridge.com/en/news/282687539.md)
- [Arcutis Biotherapeutics Targets ZORYVE Expansion, Raises 2026 Outlook and Turns Cash-Flow Positive](https://longbridge.com/en/news/282775123.md)